New Delhi: The National Pharmaceutical Pricing Authority (NPPA) has sent a notice to Faridabad's Metro Heart Institute, asking them to pay approximately Rs. 1.26 lakh as fine to the department of pharmaceuticals for allegedly overcharging patients for stents.

As per the statement issued by the pharmaceutical watchdog on Thursday, the hospital apparently overcharged two patients and made one pay Rs. 60,000 for a stent, while another was billed Rs. 1.25 lakh.


This came after the NPPA had on February 14 slashed the price of drug-eluting stents at Rs. 29,600 and bare metal at Rs. 7,000.

"It is reiterated that. for the implementation of a price cap, the effective date is the date of billing and not the date of angioplasty. If a patient has angioplasty done before February 14, 2017, and billed on February 14, 2017, or after, the patient will mandatorily get the benefit of the revised prices," read the notice issued by the NPPA.

Meanwhile the NPPA has sent notice to metro hospital to stressing on the point that the no hospital can charge for stents by a certain amount set by the authority.

Read also: Cannot exceed 8 percent trade margin on Stents: NPPA
team had earlier reported that National Pharmaceutical Pricing Authority (NPPA) received complaint against 30 hospitals for stent overcharging from patients.

In respond to the complaint the NPPA sent notices to the those 30 hospitals whereas Max Hospital in Saket, New Delhi and Nidan Hospital in Sonipat have sent detailed replies.

Read also: Complaints against 30 hospitals for stent overcharging: NPPA

Read the full notice of NPPA below;

[pdf-embedder url="https://.in/wp-content/uploads/2017/08/NPPA-notice-1.pdf"]